Flemming in 2009

Marilies Flemming (16 December 1933 – 9 July 2023[1]) was an Austrian politician who served as a Member of the European Parliament. In the European Parliament, she used the name Marialiese Flemming. She was a member of the European People's Party (Austrian People's Party domestically) and was first elected during the 1996 European Parliament election for Austria. Her European Parliamentary career ended on 19 July 2004.[2]

Career

Flemming in March 2015

Flemming initially worked in banking, then built up a film company with her husband.[3]

Flemming joined the Austrian People's Party in 1968[3] and was a member of the Municipal Council and Landtag of Vienna from 1973 until 1987,[4] after which she became head of the Ministry of Agriculture, Regions and Tourism.[5]

From 1999, Flemming served on various European Union-related delegations, committees and groups, including the Committee on the Environment, Public Health and Consumer Policy, and occasionally as a substitute on the Committee on Women's Rights (a precursor to the Committee on Women's Rights and Gender Equality) and the Committee on Research, Technological Development and Energy.[2]

Flemming also held views on human cloning in line with that of the other Christian Democrat members of the European Parliament. In 2003, she tabled more than 80 amendments[6] in the European Parliament to further restrict cloning research in European Union member states, suggesting the use of adult stem cells in research as opposed to embryos.[7] Flemming was reported by The Telegraph as saying that the creation of embryos for the purpose of medical treatment is immoral because the "individual characteristics of a person" are created at the moment of conception.[6]

In 2004, Czech Radio reported that the future European Commissioner for Health & Consumer Protection, Pavel Telička, had been involved in heated debate with Flemming over the issue of the Temelín Nuclear Power Station, a Czech nuclear power station located near the border with nuclear-free Austria. After these debates, Flemming was reported to describe Telicka as "sensational and absolutely perfect".[8]

In 2016, Flemming was a member of the Executive Committee of the European Seniors' Union.[9] In 2017, she was a representative of the Austrian Senior Council.[10]

Personal life

Marilies Flemming was born in Wiener Neustadt, Austria on 16 December 1933.[11] She engaged in language studies in Paris and at the University of Cambridge and earned a law doctorate at the University of Vienna.[12]

She was awarded the Decoration of Honour for Services to the Republic of Austria in 1990.[13]

Flemming died on 9 July 2023, at the age of 89.[11]

References

  1. ↑ https://www.parlament.gv.at/person/292
  2. 1 2 Marialiese Flemming - Your MEPs: European Parliament. Retrieved 10 February 2010.
  3. 1 2 "Marilies Flemming - Munzinger Biographie". www.munzinger.de.
  4. ↑ "Ex-ÖVP-Ministerin Marilies Flemming gestorben". news.ORF.at (in German). 13 July 2023. Retrieved 17 July 2023.
  5. ↑ "Ex-ÖVP-Ministerin Marilies Flemming gestorben". DER STANDARD (in Austrian German). Retrieved 17 July 2023.
  6. 1 2 Highfield, Roger (23 April 2003). "Is this the end for human cloning?". The Telegraph. Archived from the original (web.archive.org) on 13 November 2012. Retrieved 10 February 2010.
  7. ↑ Osborn, Andrew (11 April 2003). "MEPs vote against stem cell research". The Guardian. Retrieved 10 February 2010.
  8. ↑ Telicka passes EP test with flying colours - Czech Radio. Retrieved 10 February 2010.
  9. ↑ EUROPEAN SENIORS' UNION (ESU) Newsletter "SENIOR INTERNATIONAL" Issue No. 134 6th June 2016
  10. ↑ Report on the ninth meeting of the Bureau of the Working Group on Ageing, United Nations Economic and Social Council
  11. 1 2 "Ex-Ministerin Marilies Flemming gestorben". NOE. 13 July 2023. Retrieved 14 July 2023.
  12. ↑ Dr. Marilies Flemming
  13. ↑ Aufstellung aller durch den Bundespräsidenten verliehenen Ehrenzeichen für Verdienste um die Republik Österreich ab 1952 (PDF; 6,9 MB).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.